91
89
Growth Score
14 pts
Heat Score
88 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4249191
Servier Portugal develops and markets pharmaceutical therapies in cardiometabolic, venous, gastrointestinal, metabolic, psychiatric and onc‑
About the Company
Servier Portugal develops and markets pharmaceutical therapies across several chronic and oncology disease areas. The company focuses on treatments for hypertension, cardiovascular risk, dyslipidemia, diabetes, chronic venous disease, hemorrhoidal disease, heart failure and depression. In oncology it provides medicines for colorectal, gastric,
pancreatic and bile duct cancers, as well as acute myeloid and acute lymphoblastic leukemias. Servier Portugal also supports patient associations, scientific studies and clinical practice tools related to its therapeutic areas. In addition, it offers digital resources and medical information services for healthcare professionals through online platforms and contact channels.
